DZ Bank Call 2.374 MDGD 20.12.202.../ DE000DW83PA7 /

2024-05-24 9:34:40 PM	Chg.0.000	Bid9:55:02 PM	Ask-	Underlying	Strike price	Expiration date	Option type
0.001EUR	0.00%	0.001 Bid Size: 1,000	- Ask Size: -	MEDIGENE AG NA O.N.	2.374 EUR	2024-12-20	Call

GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...

GlobeNewswire 05-15 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS

GlobeNewswire 05-14 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

GlobeNewswire 05-07 Medigene to Present at Upcoming Conferences

GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...

GlobeNewswire 05-02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...

GlobeNewswire 05-02 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024

GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences

GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...

GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology

GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024

GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...

GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...

GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...

GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences

GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...

GlobeNewswire 2023-12-19 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-11-21 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...

GlobeNewswire 2023-11-21 Medigene amends 2023 financial guidance

GlobeNewswire 2023-11-04 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...

GlobeNewswire 2023-10-26 Medigene Reports Financial Results and Corporate Update for Q3 2023